Scott Witherspoon in Irving, Texas

Home Texas Irving

Scott Witherspoon has Ophthalmology as his primary medical specialty. Their primary office is: 400 W Interstate Hwy 635 in Irving, Texas. There is an additional office location, for a total of two, for Scott Witherspoon that can be viewed further down.

They're a part of the: Retina Institute Of Texas Pa medical group which has around 4 members. You can call their office at 972-869-1242 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Saint Louis University School Of Medicine and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Scott R Witherspoon Office Phone and Directions

Scott Witherspoon
Retina Institute Of Texas Pa
400 W Interstate Hwy 635
Irving, Texas 75063
972-869-1242

Patient Ratings
Please rate your experience with Scott Witherspoon below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 972-869-1242

Enter a starting address:

Healthcare Info for Scott Witherspoon

Medical School: Saint Louis University School Of Medicine
Graduation Year: 2003
The Primary Medical Specialty for Scott Witherspoon is listed as: Ophthalmology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 2365535408
NPI #: 1639203169
NPI Created On: 03/15/2007
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207W00000X
License Number:
N2885
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Oscar Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Injection of drug into eye
Laser destruction of eye fluid (vitreous) between the lens and retina
Laser destruction of eye fluid (vitreous) between the lens and retina
Removal of membrane from the retina, pars plana approach
Laser destruction of retinal growth, 1 or more sessions
Laser destruction of leaking retinal blood vessels, 1 or more sessions
Ultrasound of eye disease, growth, or structure
Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
Eye and medical examination for diagnosis and treatment, established patient
Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Diagnostic imaging of retina
Extended examination of eye with drawing of retina
Imaging of blood vessels in back of eye using fluorescein dye
Photography of the retina
New patient office or other outpatient visit, typically 45 minutes
Injection, aflibercept, 1 mg
Injection, ranibizumab, 0.1 mg
Compounded drug, not otherwise classified
Injection, bevacizumab, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799201203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Postoperative Inflammation

Name of Drug #1: DEXYCU

Open Associated Drug #1: 71879-001-01